Compound 60 has an extremely high affinity to MDM2 (Ki < 1 nM), strong cellular activity, and a very good oral pharmacokinetic profile. Compound sixty is capable of accomplishing total and long-lasting tumor regression in vivo and is also at this time in section I clinical trials for cancer treatment https://lomitapide99876.myparisblog.com/32337752/an-unbiased-view-of-z-4-hydroxy-tamoxifen